Article info
Clinical and epidemiological research
Concise report
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
- Correspondence to Joachim Sieper, Charité, Campus Benjamin Franklin, Medical Clinic I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany; joachim.sieper{at}charite.de
Citation
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
Publication history
- Accepted February 1, 2011
- First published March 17, 2011.
Online issue publication
June 15, 2023
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions